Alois Pískala
Academy of Sciences of the Czech Republic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alois Pískala.
Journal of Medicinal Chemistry | 2007
Marcela Krečmerová; Antonín Holý; Alois Pískala; Milena Masojídková; Graciela Andrei; Lieve Naesens; Johan Neyts; Jan Balzarini; Erik De Clercq; Robert Snoeck
Treatment of 5-azacytosine sodium salt with diisopropyl [(2-chloroethoxy)methyl]phosphonate followed by removal of ester groups with BrSi(CH3)3 afforded 1-[2-(phosphonomethoxy)ethyl]-5-azacytosine (3). Reaction of 5-azacytosine with [(trityloxy)methyl]-(2S)-oxirane followed by etherification with diisopropyl (bromomethyl)phosphonate and removal of ester groups gave 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine (1). The synthesis of 6-azacytosine congener 2 was analogous using N4-benzoylated intermediates. Compound 1 was shown to exert strong activity against a broad spectrum of DNA viruses including adenoviruses, poxviruses, and herpesviruses (i.e., herpes simplex viruses, varicella zoster virus, and human cytomegalovirus). Decomposition of 1 in alkaline solutions resulted in products 17 and 18. While the N-formylguanidine derivative 17 proved active, the carbamyolguanidine derivative 18 was devoid of antiviral activity.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Vladimír Křen; Alois Pískala; Petr Sedmera; Vladimír Havlíěek; Věra Přikrylová; Myriam Witvrouw; Erik De Clercq
Abstract N-β-D-Ribosides of agroclavine (1), elymoclavine (2), lysergene (4), lysergol (3), and 9, 10-dihydrolysergol (5) were prepared by SnCl4 catalyzed ribosylation of their TMS derivatives with 1-O-acetyl-2, 3,5-tri-O-benzoyl-β-D-ribofuranose. None of the new compounds exhibited activity against HIV or other viruses tested.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Naeem B. Hanna; Jaroslav Zajíček; Alois Pískala
Abstract The title compound was prepared by the isocyanate procedure and the tri-methylsilyl method. The measurement of 1H NMR spectrum of 6-methyl-5-azacytidine (1) revealed a preference of γt (46%) rotamer around C(5′)-C(4′) bond, a predominance of N conformation of the ribose ring (Keq 0.33) and a preference of syn conformation around the C-N glycosyl bond. An analogous measurement of 5-azacytidine has shown a preference of γ+ (60%) rotamer around the C(5′)-C(4′) bond, a predominance of N conformation of the ribose ring (Keq 0.41) and a preference of anti conformation around the C-N glycosyl bond. 6-Methyl-5-azacytidine (1) inhibits the growth of bacteria E. coli to the extent of 85% at 4000 μM concentration and the growth of LoVo/L, a human colon carcinoma cell line, to the extent of 30% at 100 μM concentration but did not inhibit L1210 cells at ≤ 100 μM concentration. 6-Methyl-5-azacytidine (1) exhibited no in vitro antiviral activity at ≤ 1 μM concentration. + Present address: Beckman, 2500 Harbor B...
Collection of Czechoslovak Chemical Communications | 1983
Alois Pískala; Abdul Hamid Rehan; Manfred Schlosser
Pharmacological Research | 2007
Miloslava Fojtová; Alois Pískala; Ivan Votruba; Miroslav Otmar; Eva Bártová; Ales Kovarik
Collection of Czechoslovak Chemical Communications | 1971
Alois Pískala; Gerd Fouquet; Manfred Zimmermann; Manfred Schlosser
Collection of Czechoslovak Chemical Communications | 1994
Ladislav Novotný; Anna Vachálková; Alois Pískala
Collection of Czechoslovak Chemical Communications | 1999
Alois Pískala; Naeem B. Hanna; Milena Masojídková; Miroslav Otmar; Pavel Fiedler; Karel Ubik
Collection of Czechoslovak Chemical Communications | 1998
Naeem B. Hanna; Milena Masojídková; Pavel Fiedler; Alois Pískala
Bioelectrochemistry and Bioenergetics | 1999
Ladislav Novotny; Anna Vachálková; Alois Pískala